Biophytis (BPTS) Halts Share Trading – Form 6-K Filed June 24 2025

Rhea-AI Filing Summary

Biophytis S.A. (ticker: BPTS) filed a Form 6-K on June 24, 2025, to alert investors that, on June 19, 2025, it issued a press release announcing the temporary suspension of trading of its shares. The filing attaches the press release as Exhibit 99.1. No further details—such as the duration, cause, or expected resolution of the suspension—are provided in the submission. The only signatory is Chairman and CEO Stanislas Veillet. Because the document offers no financial statements, earnings data, or transaction details, its sole material disclosure is the trading halt.

Positive

• None.

Negative

• Temporary suspension of share trading announced with no accompanying explanation, increasing uncertainty and potential downside risk for current and prospective investors.

Insights

Securities Analyst

TL;DR (25 words): Trading suspension notice; lack of context heightens uncertainty; negative market signal until clarified.

The filing is limited to informing the market that Biophytis shares are temporarily suspended from trading, with no explanation offered. A trading halt generally signals potential regulatory, liquidity, or corporate issues, all of which can pressure valuation. Investors have no timeline for resumption, nor insight into underlying causes, impeding risk assessment and potentially elevating volatility once trading reopens.

Risk Analyst

TL;DR (22 words): Suspension increases operational and liquidity risk; disclosure gap compounds uncertainty and could affect investor confidence.

From a risk perspective, an unclarified trading halt is a red flag. The absence of explanatory detail limits stakeholders’ ability to gauge legal, compliance, or solvency implications. Until management provides additional information, counterparty and financing risks may rise, and institutional holders could reassess exposure. The situation is materially negative unless resolved promptly with transparent communication.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Biophytis S.A. (BPTS) disclose in its June 24, 2025 Form 6-K?

The company reported that it issued a press release on June 19, 2025 announcing a temporary suspension of trading of its shares.

Is the reason for Biophytis' trading suspension stated in the filing?

No. The Form 6-K provides no details regarding the cause or expected duration of the suspension.

Where can investors find the full press release about the suspension?

The press release is attached to the Form 6-K as Exhibit 99.1.

Who signed the Biophytis Form 6-K dated June 24, 2025?

The document was signed by Stanislas Veillet, Chairman and Chief Executive Officer.

Does the filing include any financial results or earnings data?

No financial statements or earnings figures are included; the filing solely discloses the trading suspension.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/24/2025 - 12:18 PM Learn about SEC filing dates

 

 

UNITED STATES SECURITIES

AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

Date of report: June 24, 2025

 

Commission File Number: 001-38974

 

BIOPHYTIS S.A.

(Translation of registrant’s name into English)

 

 

Stanislas Veillet
Biophytis S.A.

Sorbonne University—BC 9, Bâtiment A 4ème étage

4 place Jussieu

75005 Paris, France

+33 1 44 27 23 00

(Address of principal executive office)

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

 

x Form 20-F  ¨  Form 40-F

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨

 

 

 

 

 

 

On June 19, 2025, Biophytis S.A. issued a press release announcing the temporary suspension of the trading of its shares .A copy of the press release is attached as Exhibit 99.1 to this Form 6-K.

 

EXHIBIT LIST

 

Exhibit	 	Description
99.1	 	Press Release dated January 19, 2025.

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 	BIOPHYTIS S.A.
 	 	 
Date: June 24, 2025	By:	/s/ Stanislas Veillet
 	 	Name: Stanislas Veillet
 	 	Title: Chairman and Chief Executive Officer